Advertisement
Australia markets close in 5 hours 48 minutes
  • ALL ORDS

    7,876.20
    -22.70 (-0.29%)
     
  • ASX 200

    7,618.50
    -23.60 (-0.31%)
     
  • AUD/USD

    0.6414
    -0.0011 (-0.18%)
     
  • OIL

    82.63
    -0.10 (-0.12%)
     
  • GOLD

    2,391.10
    -6.90 (-0.29%)
     
  • Bitcoin AUD

    98,448.26
    +3,157.36 (+3.31%)
     
  • CMC Crypto 200

    1,307.82
    +422.29 (+47.49%)
     
  • AUD/EUR

    0.6028
    -0.0003 (-0.05%)
     
  • AUD/NZD

    1.0875
    -0.0000 (-0.00%)
     
  • NZX 50

    11,797.09
    -38.95 (-0.33%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • NIKKEI 225

    37,555.23
    -524.47 (-1.38%)
     

Walgreens stock rises on Q2 earnings, sees decline in COVID-19 testing

Yahoo Finance Live’s Rachelle Akuffo breaks down the rise in stock for Walgreens.

Video transcript

RACHELLE AKUFFO: All right, turning now to our trending ticker. Walgreens rising after reporting a beat on estimates. The health-focused retailer seeing its business accelerate in February with its health-care unit helping offset a drop in demand it's seeing as COVID-19 cases and demand continue to wane.

Walgreens reporting a decline in both vaccinations and testing. This, of course, leading to decreased foot traffic in its stores.